Skip to main content

Table 5 Adverse events possibly related to BD induction

From: Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial

Toxicity

Grade 3

Grade 4

Grade 5

Thrombocytopenia, number (%)

8 (28.6%)

1 (3.6%)

0

Neutropenia, number (%)

2 (7.1%)

0

0

Anemia, number (%)

4 (14.3%)

0

0

Gastrointestinal, number (%)

7 (25%)

0

0

Cardiac, number (%)

3 (10.7%)

0

0

Infection, number (%)

8 (28.6%)

0

0

Acute kidney injury, number (%)

2 (7.1%)

0

0

Hepatic, number (%)

3 (10.7%)

0

0

Neuropathy

5 (17.9%)

0

0